Supporting Cancer Research
|
Events
|
Resource Library
|
Contact Us
Our Company
Our Products and
Services
Our Partners
For Investors
For Media
Careers
Corporate Social
Responsibility
For Investors
Investor Home
Why Invest?
Investor Presentation
Investor Kit
Financials
Quarterly Results
Annual Report
Archived Annual Reports
Financial Summary
SEDAR
EDGAR
Investor Kit
Report Request Form
Stock Info
Stock Quote
Historical Price Lookup
Investment Calculator
Dividend Information
Analyst Coverage
Events
2012
2011
2010
Industry Events
News Releases
2012
2011
2010
2009
2008
2007
Corporate Governance
Corporate Governance
Annual Report
Proxy Circular
Directors and Management
Board of Directors
Executive Management Team
Compensation of Directors
Board and Committee Charters
Guidelines & Practices
Disclosure Required by Section 303A.11 of NYSE
Global Business Practice Standards
FAQ
Contact IR
E-mail Alerts
Report Request Form
Home
|
News Releases 2009
12-11-2009
MDS Receives Notice of Application from PerkinElmer, Inc.
11-03-2009
MDS Inc. and Danaher Corporation Receive Second Request for Information from U.S. Federal Trade Commission for MDS Analytical Technologies Sale
11-02-2009
MDS Inc. Completes Divestiture of Central Labs Operations
10-20-2009
MDS Inc. Announces Shareholder Approval of Sale of MDS Analytical Technologies
10-09-2009
MDS Nordion Selected One of Canada's Top 100 Employers for 2010
10-09-2009
MDS Announces Agreement to Sell Central Labs Operation to Czura Thornton
10-08-2009
Leading Proxy Advisory Firms Recommend that MDS Shareholders Vote in Favour of the Divestiture of MDS Analytical Technologies
09-24-2009
MDS Files Management Proxy Circular
09-17-2009
MDS Announces CEO Transition Plan
09-10-2009
MDS Reports Third Quarter 2009 Financial Results
09-04-2009
MDS Announces Special Meeting of Shareholders and Record Date
09-03-2009
MDS to Release Third Quarter 2009 Financial Results
09-02-2009
MDS Announces Voting Support Agreements
09-02-2009
MDS Announces Strategic Repositioning
07-30-2009
MDS Nordion Submits Expression of Interest Proposal to Government of Canada on Medical Isotope and Generator Production
07-08-2009
MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage
07-01-2009
MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations
06-15-2009
MDS Nordion Collaborates With Karpov Institute of Physical Chemistry to Develop Molybdenum-99 for Global Nuclear Medicine Market
06-11-2009
MDS Reports Second Quarter 2009 Financial Results
06-10-2009
MDS Nordion Begins to Manufacture Cardiac Imaging Agent
06-08-2009
MDS Pharma Services Expands Drug Discovery Capability in Asia
06-04-2009
MDS to Release Second-Quarter 2009 Financial Results
06-02-2009
French Researchers Accelerate Biomarker Research With QTRAP(R) 5500 Mass Spectrometry Systems
06-01-2009
MDS Nordion Urges Government of Canada to Complete MAPLE Project to Address Current Medical Isotope Supply Shortage
06-01-2009
Applied Biosystems/MDS Analytical Technologies Launches New Mass Spectrometry Tools to Advance Public Health and Safety
06-01-2009
Applied Biosystems/MDS Analytical Technologies Accelerates Productivity for Drug Development and Clinical Research With New Mass Spectrometry Solution
06-01-2009
MDS Announces Strategy to Focus MDS Pharma Services on Early Stage Operations - Discovery Through Phase IIa
05-28-2009
MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium
05-19-2009
MDS Nordion Provides Update on AECL's Medical Isotope Supply Disruption
05-04-2009
MDS Nordion, TRIUMF, and the University of British Columbia Announce Partnership to Develop New Diagnostic Imaging Agents
04-28-2009
MDS Pharma Services Announces Collaboration with Compendia Bioscience, Inc. to Deliver Novel Solution for Oncology Drug Development
04-28-2009
MDS Nordion and TRIUMF Collaborate to Study Development of Photo Fission-Produced Molybdenum-99
04-27-2009
MDS Analytical Technologies Releases MetaXpressPowerCore(TM) and MetaXpress(R) 3.0 Cellular Imaging Software
04-16-2009
MDS Analytical Technologies to Showcase Imaging, Luminescence Capabilities at Society for Biomolecular Sciences Conference
04-07-2009
Applied Biosystems/MDS Analytical Technologies Launches New Mass Spectrometer to Accelerate Proteomics Research
03-18-2009
MDS Announces Renewal of Company's Shareholders Rights Plan
03-18-2009
Applied Biosystems/MDS Analytical Technologies AB SCIEX QTRAP 5500 Mass Spectrometry System Earns Scientists' Choice Award from SelectScience
03-12-2009
MDS Reports First Quarter 2009 Financial Results
03-10-2009
Applied Biosystems/MDS Analytical Technologies Launch New Test Methods to Simplify Mass Spectrometry Applications
03-10-2009
Everglades Environmental Restoration Project Aided by Mass Spectrometry Solution From Applied Biosystems/MDS Analytical Technologies
03-09-2009
MDS Nordion Launches Improved TheraSphere(R) Administration System for Physicians
03-05-2009
MDS to Release First-Quarter 2009 Financial Results
02-19-2009
MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food
02-04-2009
MDS Analytical Technologies' Laser Capture Microdissection Helps Facilitate Discovery of Potential New Colon-Cancer Biomarker
02-02-2009
MDS Announces Formation of Special Committee
01-29-2009
MDS Files 2008 Annual Reports
01-08-2009
MDS Reports Final Fourth-Quarter 2008 Results
01-07-2009
MDS Pharma Services Names Rudy Howard Chief Financial Officer
Media Alerts & Letters
06-19-2009
MDS Nordion, Belgium, Provides Update on Xenon-133
06-19-2009
MDS Nordion, Belgique, fournit une mise à jour sur le xénon-133
05-28-2009
Updated Letter to Medical Isotope Customers Regarding AECL's Supply Disruption
05-19-2009
Letter to Medical Isotope Customers Regarding AECL's Supply Disruption